CAB (conformity assessment body) activity picks up in EU/US medical devices MRA (mutual recognition agreement)
This article was originally published in Clinica
Executive Summary
Following the recent listing of the UK's SGS Yarsley as the first European conformity assessment body (CAB) authorised to conduct independent inspections on behalf of the US FDA, two more are close to being cleared. Another is not far behind, officials participating in the March MRA stakeholder teleconference heard. In all, ten EU CABs have shown interest in being part of the MRA process (see below).
You may also be interested in...
Sanofi Prepares Pulmonologists As Dupixent Nears COPD Finishing Line
The French drugmaker has identified education as a key challenge ahead of its June action date for the huge-selling IL4/IL-13 inhibitor in the lung condition. An approval would make it the first biologic for the disease.
Global Pharma Guidance Tracker – March 2024
Stay up to date on regulatory guidelines from around the world with the Pink Sheet's Guidance Tracker. The complete Global Pharma Guidance Tracker, with sortable and searchable listings going back to 2014, is available online.
EU Stakeholders Devise Six-Point Plan To Improve Cross-Border Clinical Trials
Sponsors need guidance on ethics requirements and clarity around national regulations to conduct cross-border clinical trials in the EU, a multi-stakeholder forum says.